Results 151 to 160 of about 1,741 (203)

Emerging strategies for tissue engineering in vascularized composite allotransplantation: A review. [PDF]

J Tissue Eng
Ren D, Chen J, Yu M, Yi C, Hu X, Deng J, Guo S.   +6 more
europepmc   +1 more source

C-reactive protein orchestrates acute allograft rejection in vascularized composite allotransplantation via selective activation of monocyte subsets. [PDF]

J Adv Res
Kiefer J, Zeller J, Schneider L, Thomé J, McFadyen JD, Hoerbrand IA, Lang F, Deiss E, Bogner B, Schaefer AL, Chevalier N, Horner VK, Kreuzaler S, Kneser U, Kauke-Navarro M, Braig D, Woollard KJ, Pomahac B, Peter K, Eisenhardt SU.   +19 more
europepmc   +1 more source

Mimicking Clinical Rejection Patterns in a Rat Osteomyocutaneous Flap Model of Vascularized Composite Allotransplantation. [PDF]

J Surg Res
Beare JE, Fleissig Y, Kelm NQ, Reed RM, LeBlanc AJ, Hoying JB, Kaufman CL.   +6 more
europepmc   +1 more source

Syngeneic adipose-derived stem cells with short-term immunosuppression induce vascularized composite allotransplantation tolerance in rats

Cytotherapy, 2014
A clinically applicable tolerance induction regimen that removes the requirement for lifelong immunosuppression would benefit recipients of vascularized composite allotransplantation (VCA).
Hui-Yun Cheng, Aline Yen Ling Wang, Christopher Glenn Wallace   +2 more
exaly   +2 more sources

Vascularized composite allotransplantation - a Council of Europe position paper

Transplant International, 2019
After more than 120 hand-upper extremity and 37 face transplant procedures performed worldwide, vascularized composite allotransplantation (VCA) now falls under the scope of organ transplant legislation in Europe and the United States.
Marie Thuong, Palmina Petruzzo, Luis Landin   +2 more
exaly   +2 more sources